The risk of stroke/systemic embolism and major bleeding in Asian patients with non-valvular atrial fibrillation treated with non-vitamin K oral anticoagulants compared to warfarin: Results from a real-world data analysis

Comparison of claims vs patient-reported adherence measures and associated outcomes among patients with nonvalvular atrial fibrillation using oral anticoagulant therapy

(2018) Judith J Stephenson et al.   Patient Preference and Adherence

Antithrombotic Therapy for Atrial Fibrillation

(2018) Gregory Y.H. Lip et al.   CHEST

Impact of Renal Function on Outcomes With Edoxaban in Real-World Patients With Atrial Fibrillation

(2018) Hee Tae Yu et al.   STROKE

Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients

(2018) Gregory Y.H. Lip et al.   STROKE

Outcomes After Use of Standard- and Low-Dose Non–Vitamin K Oral Anticoagulants in Asian Patients With Atrial Fibrillation

(2018) Min Soo Cho et al.   STROKE

Quality of Anticoagulation with Warfarin in Korean Patients with Atrial Fibrillation and Prior Stroke: A Multicenter Retrospective Observational Study

(2017) Keun-Sik Hong et al.   Journal of Clinical Neurology

Towards Actualizing the Value Potential of Korea Health Insurance Review and Assessment (HIRA) Data as a Resource for Health Research: Strengths, Limitations, Applications, and Strategies for Optimal Use of HIRA Data

(2017) Jee-Ae Kim et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction

(2017) Xiaoxi Yao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation

(2017) Myung-Jin Cha et al.   STROKE

CHA 2 DS 2 -VASc Score (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65–74, Female) for Stroke in Asian Patients With Atrial Fibrillation

(2017) Tae-Hoon Kim et al.   STROKE

Adherence to oral anticoagulant therapy in patients with atrial fibrillation

(2017) Roberto Cangemi et al.   THROMBOSIS AND HAEMOSTASIS

Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study

(2017) Peter Brønnum Nielsen et al.   BMJ-British Medical Journal

Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study

(2017) Peter Brønnum Nielsen et al.   BMJ-British Medical Journal

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

(2016) Paulus Kirchhof et al.   EUROPEAN HEART JOURNAL

Validation of Stroke and Thrombolytic Therapy in Korean National Health Insurance Claim Data

(2016) Tai Hwan Park et al.   Journal of Clinical Neurology

Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation

(2016) Yi-Hsin Chan et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Comparison of the Short-Term Risk of Bleeding and Arterial Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Newly Treated With Dabigatran or Rivaroxaban Versus Vitamin K AntagonistsCLINICAL PERSPECTIVES

(2015) Géric Maura et al.   CIRCULATION

Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial

(2015) Christian T Ruff et al.   LANCET

Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies

(2015) Peter C. Austin et al.   STATISTICS IN MEDICINE

Propensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs

(2014) T. Stürmer et al.   JOURNAL OF INTERNAL MEDICINE

Eligibility and Preference of New Oral Anticoagulants in Patients With Atrial Fibrillation

(2014) Chang Hyo Yoon et al.   STROKE

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments

(2013) Peter C. Austin   STATISTICS IN MEDICINE

Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation

(2012) Masatsugu Hori et al.   CIRCULATION JOURNAL

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Relative Ability of Different Propensity Score Methods to Balance Measured Covariates Between Treated and Untreated Subjects in Observational Studies

(2009) Peter C. Austin   MEDICAL DECISION MAKING

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Warfarin treatment in patients with atrial fibrillation: Observing outcomes associated with varying levels of INR control

(2008) Christopher Ll. Morgan et al.   THROMBOSIS RESEARCH